Improving lupus treatment and health outcomes through epidemiological research.
DP22-002 HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and Health
This study is looking at how lupus affects young women and people from different racial and ethnic backgrounds over time, aiming to find out more about the severity of the disease, health challenges, and early signs of kidney issues, all while gathering samples to better understand the pain and fatigue that often come with lupus.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10846549 on NIH RePORTER |
What this research studies
This research investigates the long-term effects of lupus, particularly focusing on how it impacts young women and racial/ethnic minority patients. By studying a diverse cohort of lupus patients, the project aims to understand disease severity, morbidity, and the disparities in health outcomes based on race, ethnicity, and socioeconomic status. The research also seeks to identify early signs of kidney disease in high-risk patients, which is crucial for improving management and outcomes. Additionally, it will collect biospecimens to explore the underlying causes of pain and fatigue associated with lupus.
Who could benefit from this research
Good fit: Ideal candidates for this research include young women and individuals from racial/ethnic minority groups diagnosed with lupus.
Not a fit: Patients with lupus who are not part of the targeted demographic or those with other unrelated health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and better health outcomes for lupus patients, particularly those from disadvantaged backgrounds.
How similar studies have performed: Previous research has shown promise in using epidemiological approaches to improve understanding and treatment of chronic diseases, suggesting that this approach could yield valuable insights for lupus management.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Izmirly, Peter — New York University School of Medicine
- Study coordinator: Izmirly, Peter
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.